Windtree Therapeutics

Biopharmaceuticals(Nasdaq:WINT)

关于 Windtree Therapeutics

成立时间1992
Windtree Therapeutics(Nasdaq:WINT) is a clinical-stage biopharmaceutical company focused on the treatment of cardiovascular and respiratory diseases. It develops innovative drugs including Istaroxime and is achieving business transformation and financial stability through building a crypto asset treasury, diversified financing and acquisition strategies.
社区
LinkedIn
Twitter
Website
标签
Publicly listed company
Crypto Stocks

热度值变化趋势

暂无数据

团队成员

Jed A. Latkin
Jed A. Latkin

President and CEO

Steve Simonson
Steve Simonson

Senior Vice President & Chief Medical Officer